{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:08:49Z","timestamp":1754021329357,"version":"3.28.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78996-x","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T14:37:04Z","timestamp":1731163024000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Causal role of the pyrimidine deoxyribonucleoside degradation superpathway mediation in Guillain-Barr\u00e9 Syndrome via the HVEM on CD4\u2009+\u2009and CD8\u2009+\u2009T cells"],"prefix":"10.1038","volume":"14","author":[{"given":"Xianghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"issue":"11","key":"78996_CR1","first-page":"2568","volume":"14","author":"S Liu","year":"2018","unstructured":"Liu, S., Dong, C. & Ubogu, E. E. Immunotherapy of Guillain-Barr\u00e9 syndrome. Hum Vaccin Immunother. 14(11), 2568\u20132579 (2018).","journal-title":"Hum Vaccin Immunother."},{"issue":"4","key":"78996_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4166\/kjg.2023.028","volume":"81","author":"A Lee","year":"2023","unstructured":"Lee, A. et al. Korean J Gastroenterol. 81(4), 145\u2013153 (2023).","journal-title":"Korean J Gastroenterol."},{"issue":"10280","key":"78996_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila, N., Lehmann, H. C. & Kuwabara, S. Guillain-Barr\u00e9 syndrome. Lancet. 397(10280), 1214\u20131228 (2021).","journal-title":"Lancet."},{"issue":"8","key":"78996_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg, B. et al. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 10(8), 469\u2013482 (2014).","journal-title":"Nat Rev Neurol."},{"issue":"7","key":"78996_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","volume":"9","author":"BR Wakerley","year":"2013","unstructured":"Wakerley, B. R. & Yuki, N. Infectious and noninfectious triggers in Guillain-Barr\u00e9 syndrome. Expert Rev Clin Immunol. 9(7), 627\u2013639 (2013).","journal-title":"Expert Rev Clin Immunol."},{"issue":"2","key":"78996_CR6","doi-asserted-by":"publisher","first-page":"2215153","DOI":"10.1080\/21645515.2023.2215153","volume":"19","author":"J Yao","year":"2023","unstructured":"Yao, J., Zhou, R., Liu, Y. & Lu, Z. Progress in Guillain-Barr\u00e9 syndrome immunotherapy-A narrative review of new strategies in recent years. Hum Vaccin Immunother. 19(2), 2215153 (2023).","journal-title":"Hum Vaccin Immunother."},{"issue":"4","key":"78996_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.51","volume":"68","author":"KK Nyati","year":"2011","unstructured":"Nyati, K. K., Prasad, K. N., Rizwan, A., Verma, A. & Paliwal, V. K. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome. Arch Neurol. 68(4), 445\u2013452 (2011).","journal-title":"Arch Neurol."},{"key":"78996_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.puhe.2016.12.033","volume":"145","author":"V Gupta","year":"2017","unstructured":"Gupta, V., Walia, G. K. & Sachdeva, M. P. \u201cMendelian randomization\u201d: an approach for exploring causal relations in epidemiology. Public Health. 145, 113\u2013119 (2017).","journal-title":"Public Health."},{"key":"78996_CR9","doi-asserted-by":"crossref","unstructured":"Lopera-Maya EA, Kurilshikov A, van der Graaf A, et al. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project [published correction appears in Nat Genet. 2022 Sep;54(9):1448.","DOI":"10.1038\/s41588-022-01164-2"},{"key":"78996_CR10","doi-asserted-by":"crossref","unstructured":"Qin Y, Havulinna AS, Liu Y, et al. Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort [published correction appears in Nat Genet. 2024 Mar;56(3):554.","DOI":"10.1038\/s41588-024-01693-y"},{"issue":"1","key":"78996_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","volume":"23","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry. 23(1), 590 (2023).","journal-title":"BMC Psychiatry."},{"issue":"11","key":"78996_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P., Del Greco, M. F., Pattaro, C. & K\u00f6ttgen, A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 27(11), 3253\u20133265 (2016).","journal-title":"J Am Soc Nephrol."},{"key":"78996_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/978-1-4939-7274-6_29","volume":"1666","author":"S Grover","year":"2017","unstructured":"Grover, S., Del Greco, M. F., Stein, C. M. & Ziegler, A. Mendelian Randomization. Methods Mol Biol. 1666, 581\u2013628 (2017).","journal-title":"Methods Mol Biol."},{"issue":"7","key":"78996_CR14","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.7150\/jca.92699","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen, J., Yu, X., Wu, X., Chai, K. & Wang, S. Causal relationships between gut microbiota, immune cell, and Non-small cell lung cancer: a two-step, two-sample Mendelian randomization study. J Cancer. 15(7), 1890\u20131897 (2024).","journal-title":"J Cancer."},{"key":"78996_CR15","doi-asserted-by":"crossref","unstructured":"Yuan J, Xiong X, Zhang B, et al. Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation [published correction appears in Front Endocrinol (Lausanne). 2023 Feb 23;14:1154170.","DOI":"10.3389\/fendo.2023.1154170"},{"issue":"8","key":"78996_CR16","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1007\/s10072-024-07467-y","volume":"45","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson\u2019s disease. Neurol Sci. 45(8), 3809\u20133815 (2024).","journal-title":"Neurol Sci."},{"issue":"5","key":"78996_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","volume":"36","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. Bayesian weighted Mendelian randomization for causal inference based on summary statistics. Bioinformatics. 36(5), 1501\u20131508 (2020).","journal-title":"Bioinformatics."},{"key":"78996_CR18","doi-asserted-by":"publisher","first-page":"1348347","DOI":"10.3389\/fimmu.2024.1348347","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Effect of the gut microbiome, plasma metabolome, peripheral cells, and inflammatory cytokines on obesity: a bidirectional two-sample Mendelian randomization study and mediation analysis. Front Immunol. 15, 1348347 (2024).","journal-title":"Front Immunol."},{"issue":"1","key":"78996_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12876-023-02791-7","volume":"23","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Assessing the relationship between gut microbiota and irritable bowel syndrome: a two-sample Mendelian randomization analysis. BMC Gastroenterol. 23(1), 150 (2023).","journal-title":"BMC Gastroenterol."},{"key":"78996_CR20","doi-asserted-by":"publisher","first-page":"1142140","DOI":"10.3389\/fcimb.2023.1142140","volume":"13","author":"M Luo","year":"2023","unstructured":"Luo, M. et al. Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study. Front Cell Infect Microbiol. 13, 1142140 (2023).","journal-title":"Front Cell Infect Microbiol."},{"issue":"18","key":"78996_CR21","doi-asserted-by":"publisher","first-page":"10028","DOI":"10.3390\/ijms221810028","volume":"22","author":"J Doroszkiewicz","year":"2021","unstructured":"Doroszkiewicz, J., Groblewska, M. & Mroczko, B. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System. Int J Mol Sci. 22(18), 10028 (2021).","journal-title":"Int J Mol Sci."},{"issue":"5\u20136","key":"78996_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1073858420918826","volume":"26","author":"C Vuotto","year":"2020","unstructured":"Vuotto, C., Battistini, L., Caltagirone, C. & Borsellino, G. Gut Microbiota and Disorders of the Central Nervous System. Neuroscientist. 26(5\u20136), 487\u2013502 (2020).","journal-title":"Neuroscientist."},{"key":"78996_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jad.2024.05.011","volume":"357","author":"F Cao","year":"2024","unstructured":"Cao, F., Zhang, H., Xu, B. & Li, C. Genetic association between gut microbiota and the risk of Guillain-Barr\u00e9 syndrome. J Affect Disord. 357, 171\u2013178 (2024).","journal-title":"J Affect Disord."},{"issue":"14","key":"78996_CR24","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2174\/0929867323666160411125803","volume":"23","author":"S Vincenzetti","year":"2016","unstructured":"Vincenzetti, S., Polzonetti, V., Micozzi, D. & Pucciarelli, S. Enzymology of Pyrimidine Metabolism and Neurodegeneration. Curr Med Chem. 23(14), 1408\u20131431 (2016).","journal-title":"Curr Med Chem."},{"issue":"13","key":"78996_CR25","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.3390\/ijms25137441","volume":"25","author":"GD Mironova","year":"2024","unstructured":"Mironova, G. D. et al. The Protective Effect of Uridine in a Rotenone-Induced Model of Parkinson\u2019s Disease: The Role of the Mitochondrial ATP-Dependent Potassium Channel. Int J Mol Sci. 25(13), 7441 (2024).","journal-title":"Int J Mol Sci."},{"issue":"1","key":"78996_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","volume":"229","author":"G Cai","year":"2009","unstructured":"Cai, G. & Freeman, G. J. The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev. 229(1), 244\u2013258 (2009).","journal-title":"Immunol Rev."},{"key":"78996_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3389\/fimmu.2019.01163","volume":"10","author":"J Bourque","year":"2019","unstructured":"Bourque, J. & Hawiger, D. The BTLA-HVEM-CD5 Immunoregulatory Axis-An Instructive Mechanism Governing pTreg Cell Differentiation. Front Immunol. 10, 1163 (2019).","journal-title":"Front Immunol."},{"issue":"7","key":"78996_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41423-019-0241-1","volume":"16","author":"JI Rodriguez-Barbosa","year":"2019","unstructured":"Rodriguez-Barbosa, J. I. et al. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT. Cell Mol Immunol. 16(7), 679\u2013682 (2019).","journal-title":"Cell Mol Immunol."},{"issue":"1","key":"78996_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni1144","volume":"6","author":"JR Sedy","year":"2005","unstructured":"Sedy, J. R. et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol. 6(1), 90\u201398 (2005).","journal-title":"Nat Immunol."},{"issue":"2","key":"78996_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1189\/jlb.0809590","volume":"87","author":"ML del Rio","year":"2010","unstructured":"del Rio, M. L., Lucas, C. L., Buhler, L., Rayat, G. & Rodriguez-Barbosa, J. I. HVEM\/LIGHT\/BTLA\/CD160 cosignaling pathways as targets for immune regulation. J Leukoc Biol. 87(2), 223\u2013235 (2010).","journal-title":"J Leukoc Biol."},{"key":"78996_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104532","volume":"376","author":"K Wojciechowicz","year":"2022","unstructured":"Wojciechowicz, K., Spodzieja, M., Lisowska, K. A. & Wardowska, A. The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases. Cell Immunol. 376, 104532 (2022).","journal-title":"Cell Immunol."},{"issue":"10","key":"78996_CR32","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","volume":"170","author":"L Qu\u00e9m\u00e9neur","year":"2003","unstructured":"Qu\u00e9m\u00e9neur, L. et al. Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J Immunol. 170(10), 4986\u20134995 (2003).","journal-title":"J Immunol."},{"issue":"1","key":"78996_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12879-018-3616-5","volume":"18","author":"KK Kobawaka Gamage","year":"2018","unstructured":"Kobawaka Gamage, K. K. & Fernando, H. Leptospirosis complicated with Guillain Barre syndrome, papillitis and thrombotic thrombocytopenic Purpura; a case report. BMC Infect Dis. 18(1), 691 (2018).","journal-title":"BMC Infect Dis."},{"issue":"4","key":"78996_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.36519\/idcm.2022.155","volume":"4","author":"\u00d6 Akdo\u011fan","year":"2022","unstructured":"Akdo\u011fan, \u00d6. et al. A Rare Presentation of Leptospirosis: Dysarthria and Guillain-Barr\u00e9 Syndrome. Infect Dis Clin Microbiol. 4(4), 285\u2013288 (2022).","journal-title":"Infect Dis Clin Microbiol."},{"issue":"3","key":"78996_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/0049475519836038","volume":"49","author":"N Dev","year":"2019","unstructured":"Dev, N., Kumar, R. & Kumar, D. Guillain-Barre syndrome: a rare complication of leptospirosis and scrub typhus co-infection. Trop Doct. 49(3), 248\u2013249 (2019).","journal-title":"Trop Doct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78996-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T19:03:29Z","timestamp":1731438209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78996-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78996"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78996-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27418"}}